Key result
A review of available therapies and risk models for advanced heart failure highlights the need for simple office predictors to identify patients who would benefit from advanced therapies.
This review highlights the need for better identification of advanced heart failure patients using simple office predictors to improve outcomes.
Risk models have not altered advanced HF therapies or outcomes; leaves open prospective validation and clinical integration.
Despite improvements in medical therapy for heart failure, more than 250,000 people die in the United States as a result of heart failure each year. There are multiple risk factors and models that have been created to identify these people, yet there has not been a significant impact on outcomes or change in the therapies for these patients. The authors review the available therapies for patients with advanced heart failure and the various risk models available to predict morbidity and mortality and present simple "office predictors" that could be used to potentially predict patients who would benefit from these therapies.
No takes yet. Share an insight, caveat, or question.
Russell et al. (2008) conducted a review in Advanced heart failure. Available therapies and risk models was evaluated. A review of available therapies and risk models for advanced heart failure highlights the need for simple office predictors to identify patients who would benefit from advanced therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: